JP2010530903A5 - - Google Patents

Download PDF

Info

Publication number
JP2010530903A5
JP2010530903A5 JP2010513493A JP2010513493A JP2010530903A5 JP 2010530903 A5 JP2010530903 A5 JP 2010530903A5 JP 2010513493 A JP2010513493 A JP 2010513493A JP 2010513493 A JP2010513493 A JP 2010513493A JP 2010530903 A5 JP2010530903 A5 JP 2010530903A5
Authority
JP
Japan
Prior art keywords
connexin
seq
pharmaceutical composition
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010513493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010530903A (ja
JP5552048B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/067944 external-priority patent/WO2008157840A2/en
Publication of JP2010530903A publication Critical patent/JP2010530903A/ja
Publication of JP2010530903A5 publication Critical patent/JP2010530903A5/ja
Application granted granted Critical
Publication of JP5552048B2 publication Critical patent/JP5552048B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010513493A 2007-06-21 2008-06-23 加齢性黄斑変性を治療するためのアルファコネキシンｃ末端（ａｃｔ）ペプチド Active JP5552048B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94549307P 2007-06-21 2007-06-21
US60/945,493 2007-06-21
PCT/US2008/067944 WO2008157840A2 (en) 2007-06-21 2008-06-23 Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration

Publications (3)

Publication Number Publication Date
JP2010530903A JP2010530903A (ja) 2010-09-16
JP2010530903A5 true JP2010530903A5 (enExample) 2011-08-04
JP5552048B2 JP5552048B2 (ja) 2014-07-16

Family

ID=40156983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010513493A Active JP5552048B2 (ja) 2007-06-21 2008-06-23 加齢性黄斑変性を治療するためのアルファコネキシンｃ末端（ａｃｔ）ペプチド

Country Status (5)

Country Link
US (2) US20110130345A1 (enExample)
EP (1) EP2166845B1 (enExample)
JP (1) JP5552048B2 (enExample)
DK (1) DK2166845T3 (enExample)
WO (1) WO2008157840A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408381B2 (en) 2004-12-21 2016-08-09 Musc Foundation For Research Development Alpha Connexin c-Terminal (ACT) peptides for use in transplant
EP2289535B8 (en) 2004-12-21 2018-08-08 MUSC Foundation for Research Development Compositions and methods for promoting wound healing and tissue regeneration
US20100286762A1 (en) * 2009-03-18 2010-11-11 Musc Foundation For Research Development Compositions and Methods for Ameliorating Clinical Electrical Disturbances
RU2657535C2 (ru) 2012-03-01 2018-06-14 Ферстстринг Рисерч, Инк. Гели для местного применения, содержащие с-концевые пептиды альфа-коннексина (act)
WO2013163423A1 (en) 2012-04-25 2013-10-31 Musc Foundation For Research Development Compositions and methods for wound healing and tissue repair
US10981961B2 (en) * 2013-03-11 2021-04-20 University Of Florida Research Foundation, Incorporated Delivery of card protein as therapy for occular inflammation
WO2015127094A1 (en) 2014-02-19 2015-08-27 University Of Florida Research Foundation, Inc. Delivery of nrf2 as therapy for protection against reactive oxygen species
EP4050020A1 (en) 2014-03-11 2022-08-31 University of Florida Research Foundation, Inc. Aav-expressed m013 protein as an anti-inflammatroy therapeutic for use in a method of treating inflammatory ocular disease
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
JP7185655B2 (ja) * 2014-08-22 2022-12-07 オークランド ユニサービシーズ リミティド チャネル調節剤
ES2804039A1 (es) * 2019-07-30 2021-02-02 Fund Profesor Novoa Santos Fragmentos peptidicos de cx43 para su uso como agentes senoliticos
CA3196342A1 (en) 2020-10-22 2022-04-28 Gautam Ghatnekar Peptide formulations and ophthalmic uses thereof
IL316855A (en) * 2022-05-13 2025-01-01 Character Biosciences Inc Medical fat processing preparations and methods for treating age-related macular degeneration

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601438A (enExample) 1968-10-17 1970-08-24
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
FR2739621B1 (fr) * 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
PT1146908E (pt) * 1999-01-27 2005-10-31 David Dr Becker Formulacoes que contem nucleotidos de anti-sentido para conexinas
US7250397B2 (en) * 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
WO2002088370A2 (en) * 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Autogene nucleic acids encoding a secretable rna polymerase
US6867283B2 (en) * 2001-05-16 2005-03-15 Technion Research & Development Foundation Ltd. Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells
US20050053918A1 (en) * 2001-05-16 2005-03-10 Technion Research & Development Foundation Ltd. Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
JP2003238441A (ja) * 2002-02-08 2003-08-27 英行 ▲高▼野 血管新生抑制剤
WO2003096981A2 (en) * 2002-05-15 2003-11-27 Seul, Kyung, Hwan Method of modulating angiogenesis
US7560430B2 (en) * 2003-02-14 2009-07-14 Human Matrix Sciences, Llc Elastin digest compositions and methods utilizing same
AU2004294824A1 (en) * 2003-12-03 2005-06-16 Coda Therapeutics (Nz) Ltd Antisense compounds targeted to connexins and methods of use thereof
EP2289535B8 (en) * 2004-12-21 2018-08-08 MUSC Foundation for Research Development Compositions and methods for promoting wound healing and tissue regeneration
CA2596412A1 (en) * 2005-02-03 2006-12-21 Coda Therapeutics Limited Anti-connexin compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2010530903A5 (enExample)
Betzel et al. Three‐dimensional structure of proteinase K at 0.15‐nm resolution
RU2011139724A (ru) Композиции и способы, используемые для ускорения заживления ран и регенерации тканей
Järver et al. Cell-penetrating peptides—a brief introduction
JP2010508022A5 (enExample)
CN101675067A (zh) 肽组合物的修饰以提高稳定性和递送效率
NZ704192A (en) Cell-penetrating peptides and uses therof
Dietz Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research
US20060222657A1 (en) Polypeptide transduction and fusogenic peptides
JP2015504052A5 (enExample)
ES2637277T3 (es) Nuevas moléculas inhibidoras de JNK
CO6190536A2 (es) Vacunas peptidicas para canceres que expresan antigenos asociados con tumores
JP2004532033A5 (enExample)
JP2012522501A5 (enExample)
JP2018530315A5 (enExample)
JP2010068806A5 (enExample)
JP2009525055A5 (enExample)
JP2015524403A5 (enExample)
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
CN102199214B (zh) 制备蛋白质的方法
CN116096736A (zh) 新型冠状病毒rbd融合蛋白
JP2008522954A5 (enExample)
RU2009115688A (ru) Иммуногенные гибридные полипептиды против ожирения и композиция вакцин против ожирения, содержащая эти полипептиды
CN106755042B (zh) 一种基于组合自剪切与蛋白支架的生物活性小肽制备方法
TR201900695T4 (en) HPV / CYAA-BASED CHEMICAL PROTEINS AND THEIR USE IN INDUCING IMMUNE RESPONSE AGAINST HPV INFECTION AND HPV-INDUCED DISASTER.